SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Bandaram Pharma Pack - Quaterly Results

22 Jul 2022 Evaluate
Revenue showed a marginal decline at Rs. 0.00 millions. For the quarter ended June 2022, as compared to corresponding quarter of last year.The Net Loss for the quarter ended June 2022 is Rs. -1.24 millions as compared to Net Profit of Rs. 0.00 millions of corresponding quarter ended June 2021Operating profit Margin for the quarter ended June 2022 slipped to -1.24% as compared to 0.00% of corresponding quarter ended June 2021


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202206 202106 % Var 202206 202106 % Var 202203 202103 % Var
Sales 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Other Income 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PBIDT -1.24 0.00 0.00 -1.24 0.00 0.00 -0.10 0.00 0.00
Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PBDT -1.24 0.00 0.00 -1.24 0.00 0.00 -0.10 0.00 0.00
Depreciation 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PBT -1.24 0.00 0.00 -1.24 0.00 0.00 -0.10 0.00 0.00
TAX 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PAT -1.24 0.00 0.00 -1.24 0.00 0.00 -0.10 0.00 0.00
Equity 30.00 22.77 31.75 30.00 22.77 31.75 30.00 22.77 31.75
PBIDTM(%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Bandaram Pharma Pack Share Price

27.80 0.77 (2.85%)
08-May-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1847.30
Dr. Reddys Lab 1293.25
Cipla 1347.70
Zydus Lifesciences 938.90
Lupin 2377.90
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×